Vaxart Inc (NASDAQ:VXRT) shares, rose in value, with the stock price down by -1.82% to the previous day’s close as strong demand from buyers drove the stock to $1.08.
Actively observing the price movement in the last trading, the stock closed the session at $1.10. The value of beta (5-year monthly) was 0.44. Referring to stock’s 52-week performance, its high was $1.59, and the low was $0.53. On the whole, VXRT has fluctuated by -8.86% over the past month.
With the market capitalization of Vaxart Inc currently standing at about $182.35 million, investors are eagerly awaiting this quarter’s results, scheduled for Mar 14, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be $0, which is expected to increase to $0 for fiscal year -$0.49 and then to about -$0.42 by fiscal year 2025. Data indicates that the EPS growth is expected to be 14.00% in 2025, while the next year’s EPS growth is forecast to be 14.30%.
Analysts have estimated the company’s revenue for the quarter at $2.4 million, with a low estimate of $2.4 million and a high estimate of $2.4 million. According to the average forecast, sales growth in current quarter could jump up 200.00%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $2.55 million, representing a decrease of -65.40% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that VXRT’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium term indicators have put the stock in the category of 100% Buy while long term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of VXRT currently trading nearly -11.49% and 5.67% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 43.43, while the 7-day volatility ratio is showing 7.47% which for the 30-day chart, stands at 8.30%. Furthermore, Vaxart Inc (VXRT)’s beta value is 0.44, and its average true range (ATR) is 0.09.
A comparison of Vaxart Inc (VXRT) with its peers suggests the former has fared considerably weaker in the market. VXRT showed an intraday change of -1.82% in last session, and over the past year, it grew by 42.09%%.
Data on historical trading for Vaxart Inc (NASDAQ:VXRT) indicates that the trading volumes over the past 10 days have averaged 1.39 million and over the past 3 months, they’ve averaged 1.93 million. According to company’s latest data on outstanding shares, there are 168.84 million shares outstanding.
Nearly 0.67% of Vaxart Inc’s shares belong to company insiders and institutional investors own 18.56% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 13.71 million shares as on Feb 29, 2024, resulting in a short ratio of 5.49. According to the data, the short interest in Vaxart Inc (VXRT) stood at 8.94% of shares outstanding as of Feb 29, 2024; the number of short shares registered in Jan 31, 2024 reached 11.11 million. The stock has risen by 88.55% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the VXRT stock heading into the next quarter.
